Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![USCorpFilings Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1859110030752313345.png) SEC Filings Digest [@USCorpFilings](/creator/twitter/USCorpFilings) on x 4428 followers
Created: 2025-07-23 13:45:06 UTC

$ELEV Merger of Equals:

On July 23, 2025, Elevation Oncology, Inc. completed a merger with Concentra Biosciences, after which it became a wholly owned subsidiary of Concentra, with shareholders receiving $XXXX per share plus contingent value rights. This merger follows a tender offer that saw XXXXXXXXXX shares, or approximately 67.09%, tendered by shareholders.




XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1948016522586407348/c:line.svg)

**Related Topics**
[stocks](/topic/stocks)
[corporate finance](/topic/corporate-finance)
[$elev](/topic/$elev)

[Post Link](https://x.com/USCorpFilings/status/1948016522586407348)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

USCorpFilings Avatar SEC Filings Digest @USCorpFilings on x 4428 followers Created: 2025-07-23 13:45:06 UTC

$ELEV Merger of Equals:

On July 23, 2025, Elevation Oncology, Inc. completed a merger with Concentra Biosciences, after which it became a wholly owned subsidiary of Concentra, with shareholders receiving $XXXX per share plus contingent value rights. This merger follows a tender offer that saw XXXXXXXXXX shares, or approximately 67.09%, tendered by shareholders.

XXX engagements

Engagements Line Chart

Related Topics stocks corporate finance $elev

Post Link

post/tweet::1948016522586407348
/post/tweet::1948016522586407348